Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.54 |
| ▸ | CA9 | Q16790 | 2/20 | 0.54 |
| ▸ | GLS | O94925 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | CASP3 | P42574 | 3/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | DRD3 | P35462 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | HEXA | P06865 | 1/20 | 0.47 |
| ▸ | HEXB | P07686 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.47 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.47 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL9429609 | 0.98 | CA12 (0.52) | CA12CA9GLSALDH1A1CASP3 | |
| SCHEMBL1309018 | 0.81 | HEXA (0.69) | GLSCASP3MEN1KMT2AHEXA | |
| SCHEMBL29560926 | 0.81 | HEXA (0.69) | GLSCASP3MEN1KMT2AHEXA | |
| SCHEMBL13207607 | 0.81 | HEXA (0.73) | ALDH1A1MEN1KMT2AHEXAHEXB | |
| SCHEMBL19245282 | 0.80 | TERT (0.50) | CA12CA9ALDH1A1CA1CA2 | |
| Hydrochloric Acid SCHEMBL1975097 | 0.79 | HEXA (0.67) | CA9GLSCASP3CA1CA2 | |
| Hydrochloric Acid SCHEMBL29556155 | 0.79 | HEXA (0.67) | CA9GLSCASP3CA1CA2 | |
| SCHEMBL2604740 | 0.79 | CA12 (0.58) | CA12CA9GLSALDH1A1CASP3 | |
| SCHEMBL6699936 | 0.79 | GLS (0.71) | CA12CA9GLSCASP3NPC1 | |
| SCHEMBL4063836 | 0.78 | HEXA (0.71) | GLSMEN1KMT2AHEXAHEXB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1242007-A | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising such compounds, and methods of inhibiting beta amyloid peptide release and/or its synthesis using such compounds | ELAND PHARMACEUTICAL CORP (US) | 2000-01-19 | — | — | CN | claimed |
| JP-10245502-A | — | — | None | — | — | JP | disclosed |
| JP-10245501-A | — | — | None | — | — | JP | disclosed |
| WO-2024112641-A1 | FERMENTED PLANT AND MICROBIAL-BASED FOOD PRODUCTS | THE CHEESE DESIGN LLC (US) | 2024-05-30 | — | — | WO | disclosed |
| WO-2024041737-A1 | A COMPUTER-IMPLEMENTED METHOD FOR GENERATING & USING A HYDROGEN FUEL STATION ACCESS POLICY | VOLVO TRUCK CORPORATION (SE) | 2024-02-29 | — | — | WO | disclosed |
| US-11207416-B2 | Compositions and methods for targeted RNA delivery | VERVE THERAPEUTICS, INC. (US) | 2021-12-28 | — | — | US | disclosed |
| US-20210299261-A1 | COMPOSITIONS AND METHODS FOR TARGETED RNA DELIVERY | VERVE THERAPEUTICS, INC. | 2021-09-30 | — | — | US | disclosed |
| WO-2020136163-A1 | LUBRICANT COMPOSITION FOR BALL JOINTS | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 2020-07-02 | — | — | WO | disclosed |
| EP-2563123-B1 | NOVEL BETA 3 ADRENERGIC RECEPTOR AGONISTS | MERCK SHARP & DOHME (US) | 2018-04-25 | — | — | EP | disclosed |
| US-9828352-B2 | Phenyl carbamates and their use as inhibitors of the fatty acid amide hydrolase (FAAH) enzyme and modulators of the D3 dopamine receptor (D3DR) | FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA (IT) | 2017-11-28 | — | — | US | disclosed |
| WO-2017194613-A2 | METHOD, ARRAY AND USE THEREOF | IMMUNOVIA AB (SE) | 2017-11-16 | — | — | WO | disclosed |
| CN-106432047-A | Synthesis method of astemizole drug intermediate N-(4-fluorobenzyl)phthalimide | 厦门市凯尔利信息科技有限公司 | 2017-02-22 | — | — | CN | disclosed |
| US-9550744-B2 | Vitamin C prodrugs and uses thereof | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2017-01-24 | — | — | US | disclosed |
| CN-105523989-A | Synthetic method of astemizole drug intermediate N-(4-fluorobenzyl)phthalimide | CHENGDU QIESITE TECH CO LTD | 2016-04-27 | — | — | CN | disclosed |
| EP-2042308-B1 | Planographic printing plate precursor | FUJIFILM CORP (JP) | 2011-02-23 | — | — | EP | disclosed |
| EP-2042305-B1 | Planographic printing plate precursor | FUJIFILM CORP (JP) | 2011-01-12 | — | — | EP | disclosed |
| EP-2042305-A2 | Planographic printing plate precursor | FUJIFILM Corporation (JP) | 2009-04-01 | — | — | EP | disclosed |
| JP-H10245502-A | PIGMENT COMPOSITION AND REPARATION THEREOF | TOYO INK MFG CO LTD | 1998-09-14 | — | — | JP | disclosed |
| JP-H10245501-A | PIGMENT COMPOSITION AND PREPARATION THEREOF | TOYO INK MFG CO LTD | 1998-09-14 | — | — | JP | disclosed |
| US-4950770-A | Psoralens aminomethylation | ELDER PHARMACEUTICALS, INC. (US) | 1990-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11207416-B2 | Compositions and methods for targeted RNA delivery | PCSK9, LDLR, PCSK7 | CA12 3864/4885CA9 3778/4885GLS 4141/4885 |
| US-20210299261-A1 | COMPOSITIONS AND METHODS FOR TARGETED RNA DELIVERY | PCSK9, LDLR, PCSK7 | CA12 3864/4885CA9 3778/4885GLS 4141/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.